Insights

Home » Insights » Insights Intercept Blood System
Hospital News 06/07/2018

INTERCEPT Blood System  for massively transfused patients

Large Austrian Medical Centre publishes study results on component utilization and patient safety after adoption of platelet pathogen inactivation.

The Medical University Hospital in Innsbruck has evaluated the influence of the INTERCEPT™ Blood System for platelets on component utilization and patient safety. The effectiveness of conventional vs. INTERCEPT™-treated platelets was analyzed...

Cerus 06/07/2018

2 million Swiss francs to develop a whole blood PI system in Africa

The Swiss Red Cross Humanitarian Foundation has awarded a grant of 2 million Swiss Francs to Cerus, the University Hospital of Basel, and the Swiss Transfusion SRC to complete the necessary clinical studies to develop a whole blood pathogen inactivation system for use in Africa. 

Cerus 06/07/2018

$180 million to support  development of Cerus' RBC programme

Cerus has entered an agreement with the Biomedical Advanced Research and Development Authority (BARDA) to support Cerus’ clinical development program for pathogen reduction of red blood cell (RBC) components, including access to funding that could support various activities, such as the funding of studies necessary to support an FDA submission and to accelerate commercial scale.

Cerus 04/07/2018

Cerus for charity

At Cerus, we work to enhance and save lives. We usually do this by advancing the safety, efficacy and availability of blood, but this time I’d like to ask for your support to save and enhance life in a different way.

04/07/2018

Missing Type

What if the blood groups, A, B and O were to disappear suddenly from everyday life?

Every second, thanks to blood donors, three transfusions are given around the world. But global blood services are highlighting a 28% drop in new donors compared to 10 years ago.

23/05/2018

Transfusion management during arboviral outbreak in French Polynesia

Coordinating the haemovigilance programme at the Centre Hospitalier de Polynésie Française (CHPF), the largest public hospital in French Polynesia, Dr. Damien Bierlaire is very familiar with the risks that expected as well as unexpected arboviral outbreaks can present to blood transfusion management.